Longevity PapersAbout
← All papers
RESEARCH PAPER / 2025-12-21

A role for long-lived nuclear envelope proteins in cardiac ageing.

Mathew Shuen, Regis R Lamberts, Sean Coffey, Philip W Sheard

Department of Physiology, University of Otago, Dunedin, New Zealand; HeartOtago, University of Otago, Dunedin, New Zealand.Department of Physiology, University of Otago, Dunedin, New Zealand; HeartOtago, University of Otago, Dunedin, New Zealand. · pubmed

Abstract

Ageing populations present substantial healthcare challenges, with cardiovascular disease (CVD) remaining the predominant cause of morbidity and mortality globally. Cardiac ageing is characterised by progressive cellular and molecular changes, contributing to structural and functional decline and predisposition to CVD. Component proteins (nucleoporins) of the Nuclear Pore Complex (NPC) and the nuclear lamina are both crucial for nuclear integrity and chromatin organisation, and have appeared as key players in cellular homeostasis of post-mitotic cells. Age-related changes in NPC composition and turnover, particularly in non-dividing cells, compromise nucleocytoplasmic compartmentalisation and drive genomic instability, cell death, and senescence. Emerging evidence implicates aberrant NPC components in the core hallmarks of cardiac ageing and in distinct heart diseases. Additionally, the nuclear lamina's susceptibility to damage and its interactions with NPCs might exacerbate these effects. This review presents evidence linking NPC and nuclear lamina dysfunction to features of the ageing heart and suggests that age-related NPC alterations are potential drivers of cardiomyocyte and cardiac decline with age.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

Age-related alterations in nuclear pore complex composition contribute to cardiac ageing and decline. This paper is relevant as it addresses the underlying mechanisms of cardiac ageing, linking nuclear envelope proteins to the aging process rather than merely treating symptoms of age-related diseases.

Author of this paper? Send a correction.